AmgenvsSBC Medical Group

AMGN and SBC stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$460.07

Value $248B

-0.58%
AMGN's page

SBC

SBC Medical Group Holdings Incorporated

$6.24

Value $640M

+0.97%
SBC's page

Amgen (AMGN) has a market value of $248B and SBC Medical Group (SBC) $640M. Over the last year, with dividends, AMGN moved +40.4% and SBC +88.5%. The P/E is 26.4 for AMGN and 12.3 for SBC. Dividend yield: AMGN 2.16%, SBC none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$248B

    SBC$640M

    AMGN is 387 times SBC

  • Revenue, 12 months

    AMGN$38.9B

    SBC$190M

    AMGN is 204 times SBC

  • Net income, 12 months

    AMGN$9.4B

    SBC$52M

    AMGN is 181 times SBC

  • Operating margin

    AMGN32.4%

    SBC39.9%

    7.5 points apart

  • ROIC

    AMGN16.2%

    SBC16.3%

    0.1 points apart

  • P/E

    AMGN26.4

    SBC12.3

    AMGN is 2.1 times SBC

  • Dividend yield

    AMGN2.2%

    SBC0.0%

    2.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+88.2%

SBC-41.4%

50100150200202420252026
Returns by period
PeriodAMGNWith dividendsSBCWith dividends
1 year since November 14, 2025+40.4%Price +36.6%+88.5%Price +88.5%
3 years since November 17, 2023+88.2%+23.5% a yearPrice +73.4%-41.4%-16.3% a yearPrice -41.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenSBCSBC Medical Group

Valuation

AMGNSBC
Valuation
Price$460.07$6.24
Market value$248B$640M
Enterprise value (EV)$289B$484M
P/E26.412.3
P/E, 5-year median23.011.6
P/B17.32.2
EV/EBIT22.96.4
Free cash flow yield3.9%15.7%

Results and growth

AMGNSBC
Results and growth
Revenue, 12 months$38.9B$190M
Net income, 12 months$9.4B$52M
Free cash flow, 12 months$9.6B$100M
Earnings per share, 12 months$17.25$0.50
Revenue growth, year on year10.0%-15.5%
Revenue growth a year, past+7.6%over 5 years-5.3%over 2 years
EPS growth a year, past+2.9%over 5 years+9.1%over 2 years

Margins and returns on capital

AMGNSBC
Margins and returns on capital
Gross margin70.9%72.2%
Operating margin32.4%39.9%
Net margin24.1%27.3%
ROIC16.2%16.3%
ROE87.8%19.9%

Balance sheet

AMGNSBC
Balance sheet
Cash$13.2B$199M
Total debt$54.0B$53M
Net debt / EBITDA2.3-2.0
Interest cover4.8×181.9×

Dividends and buybacks

AMGNSBC
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield–0.8%
Shareholder yield2.2%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or SBC

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or SBC Medical Group?

By market value, Amgen ($248B) is about 387.5 times SBC Medical Group ($640M), at today's prices.

How did AMGN and SBC stock do over the last 3 years?

Since November 17, 2023, AMGN's price moved +73.4% and SBC's -41.4%. With dividends: AMGN +88.2% (+23.5% a year), SBC -41.4% (-16.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or SBC?

The dividend yield at today's price is 2.16% for Amgen and none for SBC Medical Group. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and SBC?

At today's price, the P/E is 26.4 for AMGN and 12.3 for SBC. The median of the last five years was 23.0 and 11.6, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or SBC Medical Group?

Over the last twelve months, the net margin was 24.1% for Amgen and 27.3% for SBC Medical Group, and the operating margin 32.4% and 39.9%. Revenue was $38.9B and $190M.

Which is the better investment, Amgen or SBC Medical Group?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.